Q

Q32 Bio Inc.

41 employees

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Clinical Development
Autoimmunity
Therapeutics
Inflammatory
Research
Medical
Health Care

Date founded

2017

Funding rounds raised

Total raised

$60M

from 12 investors over 12 rounds

Q

Q32 Bio Inc. raised $60M on October 29, 2020

Investors: Sanofi Ventures, OrbiMed Advisors, University of Colorado, Acorn Bioventures, Abingworth, Atlas Venture and Osage University Partners (OUP)

Q

Q32 Bio Inc. raised $46M on May 27, 2020

Investors: Sanofi Ventures, Atlas Venture, University of Colorado, Abingworth and OrbiMed Advisors

FAQ